KR20130092959A - 계량된 볼륨들의 순수 또는 무균성 유동가능 물질들을 분배하기 위한 전달 시스템 - Google Patents
계량된 볼륨들의 순수 또는 무균성 유동가능 물질들을 분배하기 위한 전달 시스템 Download PDFInfo
- Publication number
- KR20130092959A KR20130092959A KR1020127029152A KR20127029152A KR20130092959A KR 20130092959 A KR20130092959 A KR 20130092959A KR 1020127029152 A KR1020127029152 A KR 1020127029152A KR 20127029152 A KR20127029152 A KR 20127029152A KR 20130092959 A KR20130092959 A KR 20130092959A
- Authority
- KR
- South Korea
- Prior art keywords
- pure
- delivery system
- sterile
- sterile materials
- valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000009969 flowable effect Effects 0.000 title claims abstract description 120
- 239000000126 substance Substances 0.000 title description 15
- 239000000463 material Substances 0.000 claims abstract description 195
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 claims abstract description 25
- 239000012530 fluid Substances 0.000 claims abstract description 17
- 238000004891 communication Methods 0.000 claims abstract 2
- 239000012528 membrane Substances 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 52
- 238000005086 pumping Methods 0.000 claims description 51
- 239000003755 preservative agent Substances 0.000 claims description 18
- 239000007924 injection Substances 0.000 claims description 16
- 238000002347 injection Methods 0.000 claims description 16
- 239000000356 contaminant Substances 0.000 claims description 14
- 210000002445 nipple Anatomy 0.000 claims description 14
- 238000007789 sealing Methods 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 9
- 230000003385 bacteriostatic effect Effects 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 230000004888 barrier function Effects 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000000845 anti-microbial effect Effects 0.000 claims description 6
- 230000006835 compression Effects 0.000 claims description 6
- 238000007906 compression Methods 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 230000013011 mating Effects 0.000 claims description 5
- 230000003068 static effect Effects 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 230000008901 benefit Effects 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000005192 partition Methods 0.000 claims description 3
- 230000001384 anti-glaucoma Effects 0.000 claims description 2
- 239000004599 antimicrobial Substances 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 238000003466 welding Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims 2
- 238000004026 adhesive bonding Methods 0.000 claims 1
- 230000003547 miosis Effects 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 238000003825 pressing Methods 0.000 abstract description 5
- 210000004379 membrane Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 8
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 8
- 229920002674 hyaluronan Polymers 0.000 description 8
- 229960003160 hyaluronic acid Drugs 0.000 description 8
- 229960004716 idoxuridine Drugs 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 229920003023 plastic Polymers 0.000 description 8
- 239000004033 plastic Substances 0.000 description 8
- 238000011109 contamination Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- 239000006196 drop Substances 0.000 description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 6
- 229920001684 low density polyethylene Polymers 0.000 description 6
- 239000004702 low-density polyethylene Substances 0.000 description 6
- 229960002748 norepinephrine Drugs 0.000 description 6
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 6
- 229920002725 thermoplastic elastomer Polymers 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 4
- 229930182837 (R)-adrenaline Natural products 0.000 description 4
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 4
- 102000003846 Carbonic anhydrases Human genes 0.000 description 4
- 108090000209 Carbonic anhydrases Proteins 0.000 description 4
- 208000010412 Glaucoma Diseases 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 210000004240 ciliary body Anatomy 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 229960005139 epinephrine Drugs 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 229920001169 thermoplastic Polymers 0.000 description 4
- 239000004416 thermosoftening plastic Substances 0.000 description 4
- 229960004605 timolol Drugs 0.000 description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 239000002876 beta blocker Substances 0.000 description 3
- 229940097320 beta blocking agent Drugs 0.000 description 3
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 description 3
- 229960000722 brinzolamide Drugs 0.000 description 3
- HCRKCZRJWPKOAR-JTQLQIEISA-N brinzolamide Chemical compound CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S(N)(=O)=O)S2 HCRKCZRJWPKOAR-JTQLQIEISA-N 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 229960003933 dorzolamide Drugs 0.000 description 3
- IAVUPMFITXYVAF-XPUUQOCRSA-N dorzolamide Chemical compound CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S(N)(=O)=O)S2 IAVUPMFITXYVAF-XPUUQOCRSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229960000571 acetazolamide Drugs 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000001742 aqueous humor Anatomy 0.000 description 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
- 229960004324 betaxolol Drugs 0.000 description 2
- NWIUTZDMDHAVTP-UHFFFAOYSA-N betaxolol Chemical compound C1=CC(OCC(O)CNC(C)C)=CC=C1CCOCC1CC1 NWIUTZDMDHAVTP-UHFFFAOYSA-N 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940119743 dextran 70 Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229960003943 hypromellose Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940112534 lumigan Drugs 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- MKPLKVHSHYCHOC-AHTXBMBWSA-N travoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(C(F)(F)F)=C1 MKPLKVHSHYCHOC-AHTXBMBWSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XYLJNLCSTIOKRM-UHFFFAOYSA-N Alphagan Chemical compound C1=CC2=NC=CN=C2C(Br)=C1NC1=NCCN1 XYLJNLCSTIOKRM-UHFFFAOYSA-N 0.000 description 1
- WJTLIFNCKKFFLZ-UHFFFAOYSA-N BSS Chemical compound BSS WJTLIFNCKKFFLZ-UHFFFAOYSA-N 0.000 description 1
- OKKZZTWDFXEJAH-LRWPTBCASA-N CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 Chemical compound CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 OKKZZTWDFXEJAH-LRWPTBCASA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 208000023715 Ocular surface disease Diseases 0.000 description 1
- 241000289371 Ornithorhynchus anatinus Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- PIJVFDBKTWXHHD-UHFFFAOYSA-N Physostigmine Natural products C12=CC(OC(=O)NC)=CC=C2N(C)C2C1(C)CCN2C PIJVFDBKTWXHHD-UHFFFAOYSA-N 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 229960003216 aceclidine Drugs 0.000 description 1
- WRJPSSPFHGNBMG-UHFFFAOYSA-N acetic acid 1-azabicyclo[2.2.2]octan-3-yl ester Chemical compound C1CC2C(OC(=O)C)CN1CC2 WRJPSSPFHGNBMG-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229960002610 apraclonidine Drugs 0.000 description 1
- IEJXVRYNEISIKR-UHFFFAOYSA-N apraclonidine Chemical compound ClC1=CC(N)=CC(Cl)=C1NC1=NCCN1 IEJXVRYNEISIKR-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 229960004374 befunolol Drugs 0.000 description 1
- ZPQPDBIHYCBNIG-UHFFFAOYSA-N befunolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=C1OC(C(C)=O)=C2 ZPQPDBIHYCBNIG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960002470 bimatoprost Drugs 0.000 description 1
- 229960003679 brimonidine Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 229960001222 carteolol Drugs 0.000 description 1
- LWAFSWPYPHEXKX-UHFFFAOYSA-N carteolol Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(O)CNC(C)(C)C LWAFSWPYPHEXKX-UHFFFAOYSA-N 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 229960002947 dapiprazole Drugs 0.000 description 1
- RFWZESUMWJKKRN-UHFFFAOYSA-N dapiprazole Chemical compound CC1=CC=CC=C1N1CCN(CCC=2N3CCCCC3=NN=2)CC1 RFWZESUMWJKKRN-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- RWZVPVOZTJJMNU-UHFFFAOYSA-N demarcarium Chemical compound C=1C=CC([N+](C)(C)C)=CC=1OC(=O)N(C)CCCCCCCCCCN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 RWZVPVOZTJJMNU-UHFFFAOYSA-N 0.000 description 1
- 229960004656 demecarium Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940099238 diamox Drugs 0.000 description 1
- 229960005081 diclofenamide Drugs 0.000 description 1
- GJQPMPFPNINLKP-UHFFFAOYSA-N diclofenamide Chemical compound NS(=O)(=O)C1=CC(Cl)=C(Cl)C(S(N)(=O)=O)=C1 GJQPMPFPNINLKP-UHFFFAOYSA-N 0.000 description 1
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 1
- OCUJLLGVOUDECM-UHFFFAOYSA-N dipivefrin Chemical compound CNCC(O)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1 OCUJLLGVOUDECM-UHFFFAOYSA-N 0.000 description 1
- 229960000966 dipivefrine Drugs 0.000 description 1
- IKALZAKZWHFNIC-JIZZDEOASA-L dipotassium;(2s)-2-aminobutanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O IKALZAKZWHFNIC-JIZZDEOASA-L 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229960002017 echothiophate Drugs 0.000 description 1
- BJOLKYGKSZKIGU-UHFFFAOYSA-N ecothiopate Chemical compound CCOP(=O)(OCC)SCC[N+](C)(C)C BJOLKYGKSZKIGU-UHFFFAOYSA-N 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960005051 fluostigmine Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960003602 guanethidine Drugs 0.000 description 1
- ACGDKVXYNVEAGU-UHFFFAOYSA-N guanethidine Chemical compound NC(N)=NCCN1CCCCCCC1 ACGDKVXYNVEAGU-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- XXUPXHKCPIKWLR-JHUOEJJVSA-N isopropyl unoprostone Chemical compound CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OC(C)C XXUPXHKCPIKWLR-JHUOEJJVSA-N 0.000 description 1
- 229960001160 latanoprost Drugs 0.000 description 1
- 229960000831 levobunolol Drugs 0.000 description 1
- IXHBTMCLRNMKHZ-LBPRGKRZSA-N levobunolol Chemical compound O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C IXHBTMCLRNMKHZ-LBPRGKRZSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229960004083 methazolamide Drugs 0.000 description 1
- FLOSMHQXBMRNHR-DAXSKMNVSA-N methazolamide Chemical compound CC(=O)\N=C1/SC(S(N)(=O)=O)=NN1C FLOSMHQXBMRNHR-DAXSKMNVSA-N 0.000 description 1
- 239000012569 microbial contaminant Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 229960002362 neostigmine Drugs 0.000 description 1
- ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 description 1
- OSZNNLWOYWAHSS-UHFFFAOYSA-M neostigmine methyl sulfate Chemical compound COS([O-])(=O)=O.CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 OSZNNLWOYWAHSS-UHFFFAOYSA-M 0.000 description 1
- 229960002253 neostigmine methylsulfate Drugs 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229960004623 paraoxon Drugs 0.000 description 1
- WYMSBXTXOHUIGT-UHFFFAOYSA-N paraoxon Chemical compound CCOP(=O)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 WYMSBXTXOHUIGT-UHFFFAOYSA-N 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960001697 physostigmine Drugs 0.000 description 1
- PIJVFDBKTWXHHD-HIFRSBDPSA-N physostigmine Chemical compound C12=CC(OC(=O)NC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C PIJVFDBKTWXHHD-HIFRSBDPSA-N 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 229940053174 restasis Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940080150 systane Drugs 0.000 description 1
- 229940036266 tears naturale Drugs 0.000 description 1
- 229940021790 tetrahydrozoline hydrochloride Drugs 0.000 description 1
- BJORNXNYWNIWEY-UHFFFAOYSA-N tetrahydrozoline hydrochloride Chemical compound Cl.N1CCN=C1C1C2=CC=CC=C2CCC1 BJORNXNYWNIWEY-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940113006 travatan Drugs 0.000 description 1
- 229960002368 travoprost Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229960004317 unoprostone Drugs 0.000 description 1
- TVHAZVBUYQMHBC-SNHXEXRGSA-N unoprostone Chemical compound CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O TVHAZVBUYQMHBC-SNHXEXRGSA-N 0.000 description 1
- 229950008081 unoprostone isopropyl Drugs 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 229940002639 xalatan Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16813—Flow controllers by controlling the degree of opening of the flow line
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D35/00—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor
- B65D35/24—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor with auxiliary devices
- B65D35/36—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor with auxiliary devices for applying contents to surfaces
- B65D35/38—Nozzles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D34/00—Containers or accessories specially adapted for handling liquid toiletry or cosmetic substances, e.g. perfumes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0062—Outlet valves actuated by the pressure of the fluid to be sprayed
- B05B11/007—Outlet valves actuated by the pressure of the fluid to be sprayed being opened by deformation of a sealing element made of resiliently deformable material, e.g. flaps, skirts, duck-bill valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
- B05B11/026—Membranes separating the content remaining in the container from the atmospheric air to compensate underpressure inside the container
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1028—Pumps having a pumping chamber with a deformable wall
- B05B11/1032—Pumps having a pumping chamber with a deformable wall actuated without substantial movement of the nozzle in the direction of the pressure stroke
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Mechanical Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34188910P | 2010-04-06 | 2010-04-06 | |
| US61/341,889 | 2010-04-06 | ||
| US45806510P | 2010-11-17 | 2010-11-17 | |
| US61/458,065 | 2010-11-17 | ||
| PCT/US2011/000631 WO2011126569A1 (en) | 2010-04-06 | 2011-04-06 | Delivery system for dispensing metered volumes of pure or sterile flowable substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20130092959A true KR20130092959A (ko) | 2013-08-21 |
Family
ID=44763209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020127029152A Withdrawn KR20130092959A (ko) | 2010-04-06 | 2011-04-06 | 계량된 볼륨들의 순수 또는 무균성 유동가능 물질들을 분배하기 위한 전달 시스템 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9241828B2 (https=) |
| EP (1) | EP2555994A4 (https=) |
| JP (1) | JP6125996B2 (https=) |
| KR (1) | KR20130092959A (https=) |
| CN (1) | CN103038141A (https=) |
| AU (1) | AU2011238914A1 (https=) |
| BR (1) | BR112012025667A2 (https=) |
| CA (1) | CA2795675A1 (https=) |
| IL (1) | IL222282B (https=) |
| MX (2) | MX342863B (https=) |
| RU (1) | RU2012147273A (https=) |
| SG (1) | SG184478A1 (https=) |
| WO (1) | WO2011126569A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR200487135Y1 (ko) * | 2018-06-27 | 2018-09-10 | 이성환 | 선스틱 용기 |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
| WO2012151295A2 (en) * | 2011-05-02 | 2012-11-08 | Mouse Trap Design, Llc | Mixing and dispensing device |
| AR086400A1 (es) | 2011-05-13 | 2013-12-11 | Trimel Pharmaceuticals Corp | Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo |
| US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
| US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| IN2014DN03437A (https=) * | 2011-10-21 | 2015-06-05 | Leo Pharma As | |
| JP2015503992A (ja) | 2012-01-17 | 2015-02-05 | ドクター ピー インスティチュート エルエルシー | 複数回投与用シリンジおよび方法 |
| US9737435B2 (en) | 2012-01-20 | 2017-08-22 | Dr. Py Institute Llc | Device with closure, one-way valve, and storage chamber and related method |
| FR2994865B1 (fr) | 2012-09-05 | 2014-09-26 | Rexam Dispensing Sys | Tete de distribution pour un systeme de distribution d’un produit sous pression |
| WO2014076569A2 (en) * | 2012-11-14 | 2014-05-22 | Trimel Biopharma Srl | Controlled release topical testosterone formulations and methods |
| US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
| AU2014324161B2 (en) * | 2013-09-17 | 2017-11-16 | Boehringer Ingelheim Animal Health USA Inc. | Multi-chamber, multi-formulation fluid delivery system |
| GR1008330B (el) * | 2013-10-17 | 2014-10-20 | "Φαρματεν Α.Β.Ε.Ε.", | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση εχoν βελτιωμενες φυσικες ιδιοτητες και ογκο σταγονας |
| RU2687770C2 (ru) * | 2013-11-05 | 2019-05-16 | Новартис Аг | Офтальмологическая система смазки и сопутствующие приборы, системы и способы |
| FR3015443B1 (fr) * | 2013-12-23 | 2016-07-01 | Lablabo | Dispositif de conditionnement et de distribution de produits fluides, liquides ou pateux |
| JP6554478B2 (ja) | 2014-03-17 | 2019-07-31 | インテュイティブ サージカル オペレーションズ, インコーポレイテッド | 手術器具を遠隔操作アクチュエータと係合させる方法 |
| KR102437468B1 (ko) | 2014-03-17 | 2022-08-30 | 인튜어티브 서지컬 오퍼레이션즈 인코포레이티드 | 디스크 결합을 확인하는 시스템 및 방법 |
| FR3023734B1 (fr) * | 2014-07-17 | 2021-11-05 | Albea Le Treport | Tete de distribution pour un systeme de distribution d'un produit |
| US20160058155A1 (en) * | 2014-09-02 | 2016-03-03 | HCT Group Holdings Limited | Container with dispensing tip |
| CN113230021A (zh) | 2015-01-12 | 2021-08-10 | 科达莱昂治疗公司 | 微滴递送设备和方法 |
| JP2018515153A (ja) | 2015-04-10 | 2018-06-14 | ケダリオン セラピューティックス,インコーポレイテッド | 交換式アンプルを備えた圧電式ディスペンサ |
| CN106691845B (zh) * | 2015-07-22 | 2023-11-03 | 北京万生人和科技有限公司 | 一种膏体定量装置 |
| CN205196997U (zh) * | 2015-11-04 | 2016-05-04 | 深圳市合元科技有限公司 | 用于电子烟的储液器以及雾化器和电子烟 |
| WO2017189873A1 (en) * | 2016-04-27 | 2017-11-02 | Innovationcooperative3D, Llc | Adjustable dosing fluid dispenser for flexible fluid packages |
| FR3052989B1 (fr) * | 2016-06-27 | 2020-02-21 | Aptar France Sas | Ensemble de distribution et d'application de produit fluide |
| CN109562403A (zh) * | 2016-07-12 | 2019-04-02 | 艾露空气有限公司 | 用于流体容器的泵装置 |
| KR102412086B1 (ko) | 2017-01-20 | 2022-06-22 | 켄달리온 테라퓨틱스 인코포레이티드 | 압전 유체 분배기 |
| JP6612839B2 (ja) * | 2017-03-10 | 2019-11-27 | テヤン レナー カンパニー、リミテッド | 化粧容器 |
| MX2019014016A (es) * | 2017-05-31 | 2020-02-17 | Philip Morris Products Sa | Articulo inhalador con elemento de flujo de aire ocluido. |
| JP7227163B2 (ja) | 2017-06-10 | 2023-02-21 | アイノビア,インコーポレイティド | 流体を取扱い、目に流体を送出するための方法および装置 |
| MA50022A (fr) | 2017-08-30 | 2020-07-08 | Novo Nordisk As | Unité de communication d'écoulement dotée d'un conservateur |
| MA50021A (fr) | 2017-08-30 | 2020-07-08 | Novo Nordisk As | Dispositif d'administration de médicament à usages multiples pour des médicaments avec moins de conservateurs |
| KR101862201B1 (ko) | 2017-08-31 | 2018-05-29 | 제이에스케이바이오메드(주) | 역류방지밸브가 구비된 마이크로젯 약물 주사 장치 |
| CN107811395B (zh) * | 2017-09-14 | 2019-11-19 | 浙江伟飒塑业有限公司 | 一种膏体化妆品包装容器 |
| CN107654840B (zh) * | 2017-10-31 | 2023-09-05 | 厚普清洁能源(集团)股份有限公司 | 一种分度式氢燃料电池汽车加氢枪 |
| EP3704448B1 (en) | 2017-11-02 | 2022-06-01 | F. Hoffmann-La Roche AG | Droplet dispensing device and system |
| WO2019113483A1 (en) | 2017-12-08 | 2019-06-13 | Kedalion Therapeutics, Inc. | Fluid delivery alignment system |
| US12350194B1 (en) | 2018-04-12 | 2025-07-08 | Bausch + Lomb Ireland Limited | Topical ocular delivery of fluids with controlled mass dosing and wireless communication |
| US20190314197A1 (en) | 2018-04-12 | 2019-10-17 | Kedalion Therapeutics, Inc. | Topical Ocular Delivery Methods and Devices for Use in the Same |
| EP3773794B1 (en) | 2018-04-13 | 2025-12-17 | Novo Nordisk A/S | Flow communication unit with unconnected and connected configuration |
| JP6646782B2 (ja) * | 2018-05-11 | 2020-02-14 | 科研製薬株式会社 | 塗布具及びそのアプリケータシステム |
| KR102529972B1 (ko) * | 2018-06-18 | 2023-05-08 | 에프엘스미쓰 에이/에스 | 부을 수 있는 재료를 연속적으로 중량 계량하기 위한 장치 |
| WO2020010116A1 (en) | 2018-07-03 | 2020-01-09 | Kedalion Therapeutics, Inc. | Topical ocular delivery devices and methods for using the same |
| CN109123993B (zh) * | 2018-08-21 | 2021-04-16 | 上海美浮特生物科技有限公司 | 一种硅胶指腹涂抹式眼霜 |
| CN109498261A (zh) * | 2018-12-07 | 2019-03-22 | 张家港众辉医用塑料科技有限公司 | 一种无残留滴液器 |
| US12097145B2 (en) | 2019-03-06 | 2024-09-24 | Bausch + Lomb Ireland Limited | Vented multi-dose ocular fluid delivery system |
| US11679028B2 (en) | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
| CN113543752B (zh) * | 2019-03-06 | 2024-10-15 | 博士伦爱尔兰有限公司 | 多剂量眼流体输送系统 |
| EP3730220B1 (de) * | 2019-04-26 | 2022-07-06 | Aptar Radolfzell GmbH | Spender zum austrag pharmazeutischer flüssigkeiten |
| ES2908081T3 (es) * | 2019-05-16 | 2022-04-27 | Brill Engines S L | Un dispositivo apto para la dispensación de sustancias líquidas |
| US12082611B2 (en) | 2019-05-24 | 2024-09-10 | Imperial Tobacco Limited | Aerosol delivery device |
| EP3741463A1 (en) * | 2019-05-24 | 2020-11-25 | Nerudia Limited | Aerosol delivery device |
| GB2585206B (en) * | 2019-07-01 | 2021-08-11 | Merxin Ltd | Portable inhaler |
| US12496218B1 (en) | 2019-11-12 | 2025-12-16 | Bausch + Lomb Ireland Limited | Fractionated topical ocular drug delivery methods and devices for use in the same |
| WO2021119513A1 (en) * | 2019-12-11 | 2021-06-17 | Eyenovia, Inc. | Systems and devices for delivering fluids to the eye and methods of use |
| MX2022007514A (es) * | 2019-12-18 | 2022-09-19 | Janssen Pharmaceutica Nv | Sistemas de envasado para dispositivos de suministro de fármacos y kits de envasado. |
| KR102424862B1 (ko) * | 2020-01-28 | 2022-07-26 | 투바이오스 주식회사 | 체내 이식형 수동 제어 약물전달 장치 |
| US11090666B1 (en) | 2020-01-29 | 2021-08-17 | Over the Top Foods, Inc. | Dispensation devices and methods of manufacture and use thereof |
| US12090087B2 (en) | 2020-04-17 | 2024-09-17 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir |
| CN115768384A (zh) | 2020-04-17 | 2023-03-07 | 科达隆治疗公司 | 流体动力致动的不含防腐剂分配系统 |
| US11938057B2 (en) | 2020-04-17 | 2024-03-26 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
| US12290472B2 (en) | 2020-04-17 | 2025-05-06 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
| CA3180947A1 (en) * | 2020-06-01 | 2021-12-09 | Dane Hassani | Intravenous fluid delivery system and apparatus |
| GB202008867D0 (en) | 2020-06-11 | 2020-07-29 | Dispenser Tech Limited | Improvements in or relating to fluid delivery devices |
| LU102197B1 (de) * | 2020-11-12 | 2022-05-12 | Gleixner Holding Gmbh & Co Kg | Dispensiervorrichtung zum Dispensieren eines flüssigen Mediums, insbesondere einer Augenflüssigkeit |
| EP4049700A1 (en) * | 2021-02-25 | 2022-08-31 | Sanofi | Fluid dispensing device |
| DE102021111630A1 (de) * | 2021-05-05 | 2022-11-10 | Henke-Sass, Wolf Gmbh | Vorrichtung zur tropfenweisen Abgabe eines Fluids |
| EP4353624A4 (en) | 2021-06-07 | 2025-05-14 | Eric Zembrod | CHECK VALVE FOR VARIOUS PACKAGING |
| EP4147787A1 (de) * | 2021-09-10 | 2023-03-15 | Aptar Radolfzell GmbH | Flüssigkeitsspender |
| CN117297246A (zh) * | 2023-11-14 | 2023-12-29 | 上海英宇包装科技有限公司 | 具有减速功能的按压出料化妆品容器 |
| WO2025132426A1 (en) * | 2023-12-18 | 2025-06-26 | EyeNeb GmbH | Pumping unit for modular application device |
| WO2026022375A1 (en) * | 2024-07-26 | 2026-01-29 | Philip Morris Products S.A. | Aerosol-delivery device with inclined trigger actuation direction |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715980A (en) * | 1950-10-09 | 1955-08-23 | Leo M Harvey | Liquid handling dispenser |
| US2989215A (en) * | 1958-03-03 | 1961-06-20 | John H Willingham | Dispenser for material containers |
| US3220611A (en) * | 1964-08-14 | 1965-11-30 | Waldo H Zander | Wall mounted bracket and dispenser for collapsible tube |
| SE333624B (https=) * | 1969-07-28 | 1971-03-22 | Perpedos Ab | |
| US3902815A (en) * | 1974-04-01 | 1975-09-02 | Liquid Paper Corp | Positive displacement dispenser |
| US3963147A (en) * | 1975-01-08 | 1976-06-15 | The Raymond Lee Organization, Inc. | Dispenser for amorphous material |
| GB2062771B (en) * | 1979-10-15 | 1983-06-29 | Tranas Rostfria Ab | Dispensing device |
| US4308965A (en) | 1979-10-24 | 1982-01-05 | Sun Coast Plastic Closures, Inc. | Unitary cap of two dissimilar materials |
| US4415121A (en) * | 1981-06-12 | 1983-11-15 | The Reseal Corporation Of America | Valve for spraying a mist |
| DE4018147A1 (de) * | 1990-02-24 | 1991-08-29 | Weener Plastik Gmbh Co Kg | Ventilkoerper |
| US5044523A (en) * | 1990-02-28 | 1991-09-03 | Photofinish Cosmetics Inc. | Method and apparatus for dispensing of volatile fluids |
| DE4027320C2 (de) * | 1990-08-29 | 1993-09-30 | Ursapharm Arzneimittel Gmbh | Fluid-Abgabeeinrichtung für keimfreies Fluid |
| US5373972A (en) * | 1991-11-15 | 1994-12-20 | Jsp Partners, L.P. | Preservative-free sterile fluid dispensing system |
| EP0840630B1 (en) * | 1995-06-07 | 2009-05-06 | O'NEIL, Christine | Patient controlled drug delivery device |
| US5865795A (en) * | 1996-02-29 | 1999-02-02 | Medi-Ject Corporation | Safety mechanism for injection devices |
| US5836484A (en) * | 1996-10-03 | 1998-11-17 | Gerber; Bernard R. | Contamination-safe multiple-dose dispensing cartridge for flowable materials |
| US5944226A (en) * | 1997-06-09 | 1999-08-31 | Liquid Control Corporation | Add-on valve assembly for dual-component cartridge |
| CH693413A5 (de) * | 1998-02-10 | 2003-07-31 | Mrp Medical Res & Promotion Es | Mehrfachdosierflasche mit Dosierungsausguss für Produkte, insbesondere Medizin. |
| FR2778173B1 (fr) * | 1998-04-29 | 2000-06-30 | Jean Charles Nickels | Dispositif hermetique de distribution de fluide |
| US6200055B1 (en) * | 1999-06-18 | 2001-03-13 | Stephen Gould Corporation | Dispenser device for dispensing metered doses of viscous material |
| US6325253B1 (en) * | 2001-02-02 | 2001-12-04 | Owens-Illinois Closure Inc. | Self-closing fluid dispensing closure |
| US6702155B1 (en) * | 2001-09-18 | 2004-03-09 | Solvay Pharmaceuticals, Inc. | Metered dose dispenser |
| US6766816B2 (en) * | 2001-10-03 | 2004-07-27 | Hunter Group, Inc. | Collapsible dispensing system |
| US6662977B2 (en) * | 2002-03-14 | 2003-12-16 | Bernard R. Gerber | Modular valve assembly and system with airtight, leakproof and shockproof closure for engagement in the neck of a container |
| JP4037792B2 (ja) * | 2002-09-06 | 2008-01-23 | 住友ゴム工業株式会社 | 容器の逆流防止口栓および容器ならびに注出装置 |
| FR2847889B1 (fr) * | 2002-11-29 | 2005-03-04 | Dispositif de distribution de produit fluide | |
| GB0305583D0 (en) * | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | A fluid dispensing device |
| US7243682B2 (en) * | 2003-10-02 | 2007-07-17 | Brandes Raymond V | Annular one-way valve |
| GB0402695D0 (en) * | 2004-02-06 | 2004-03-10 | Glaxo Group Ltd | A metering pump system |
| US7306129B2 (en) * | 2005-11-03 | 2007-12-11 | Stewart Swiss | One way valve assembly |
| TW200733993A (en) * | 2005-11-03 | 2007-09-16 | Reseal Internat Ltd Partnership | Continuously sealing one way valve assembly and fluid delivery system and formulations for use therein |
| TW200735906A (en) * | 2005-11-03 | 2007-10-01 | Rseal Internat Ltd Partnership | Continuously sealing one way valve assembly and fluid delivery system and formulations for use therein |
| US7874467B2 (en) * | 2005-11-03 | 2011-01-25 | Reseal International Limited Partnership | Metered drop push button dispenser system |
| DE102006012898A1 (de) * | 2006-03-13 | 2007-09-20 | Ing. Erich Pfeiffer Gmbh | Austragvorrichtung für ein fließfähiges Medium |
| US7997453B1 (en) * | 2006-07-09 | 2011-08-16 | Yuri Gallegos | Fluid pumping dispenser |
| CN2937092Y (zh) * | 2006-08-02 | 2007-08-22 | 袁建军 | 一种新型液体分配器 |
| WO2008027382A2 (en) | 2006-08-31 | 2008-03-06 | Meridian Medical Technologies, Inc. | Vortex feature for drug delivery system |
-
2011
- 2011-04-06 AU AU2011238914A patent/AU2011238914A1/en not_active Abandoned
- 2011-04-06 MX MX2012011663A patent/MX342863B/es active IP Right Grant
- 2011-04-06 RU RU2012147273/12A patent/RU2012147273A/ru not_active Application Discontinuation
- 2011-04-06 CA CA2795675A patent/CA2795675A1/en not_active Abandoned
- 2011-04-06 SG SG2012074357A patent/SG184478A1/en unknown
- 2011-04-06 EP EP11766276.7A patent/EP2555994A4/en not_active Withdrawn
- 2011-04-06 MX MX2016013505A patent/MX371253B/es unknown
- 2011-04-06 CN CN2011800245677A patent/CN103038141A/zh active Pending
- 2011-04-06 JP JP2013503745A patent/JP6125996B2/ja active Active
- 2011-04-06 US US13/066,153 patent/US9241828B2/en not_active Expired - Fee Related
- 2011-04-06 KR KR1020127029152A patent/KR20130092959A/ko not_active Withdrawn
- 2011-04-06 BR BR112012025667A patent/BR112012025667A2/pt active Search and Examination
- 2011-04-06 WO PCT/US2011/000631 patent/WO2011126569A1/en not_active Ceased
-
2012
- 2012-10-09 IL IL222282A patent/IL222282B/en not_active IP Right Cessation
-
2015
- 2015-12-10 US US14/965,474 patent/US9867933B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR200487135Y1 (ko) * | 2018-06-27 | 2018-09-10 | 이성환 | 선스틱 용기 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL222282B (en) | 2018-03-29 |
| EP2555994A1 (en) | 2013-02-13 |
| BR112012025667A2 (pt) | 2016-06-28 |
| MX342863B (es) | 2016-10-17 |
| JP6125996B2 (ja) | 2017-05-17 |
| RU2012147273A (ru) | 2014-05-20 |
| AU2011238914A1 (en) | 2012-11-29 |
| MX2012011663A (es) | 2013-01-24 |
| SG184478A1 (en) | 2012-11-29 |
| US9867933B2 (en) | 2018-01-16 |
| JP2013523317A (ja) | 2013-06-17 |
| WO2011126569A1 (en) | 2011-10-13 |
| US20160263314A1 (en) | 2016-09-15 |
| EP2555994A4 (en) | 2014-02-19 |
| US20110284579A1 (en) | 2011-11-24 |
| MX371253B (es) | 2020-01-23 |
| CA2795675A1 (en) | 2011-10-13 |
| CN103038141A (zh) | 2013-04-10 |
| US9241828B2 (en) | 2016-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20130092959A (ko) | 계량된 볼륨들의 순수 또는 무균성 유동가능 물질들을 분배하기 위한 전달 시스템 | |
| ES2442017T3 (es) | Sistema de dispensador de dosis medidas con botón pulsador | |
| US7678089B2 (en) | Delivery device and method of delivery | |
| EP1948523B1 (en) | One way valve assembly | |
| US10993835B2 (en) | Device for packaging and dispensing a substance for ophthalmic use | |
| CN101374728A (zh) | 单向阀门零件 | |
| CN101296754A (zh) | 液体分配器 | |
| KR20080093971A (ko) | 연속적인 밀봉의 일 방향 밸브 어셈블리 및 그 내부에서의이용을 위한 유체 전달 시스템 제조물 | |
| KR20100076967A (ko) | 계량식 액적 푸시 버튼 분배기 시스템 | |
| JP2019069087A (ja) | 眼科用薬液投与器及び薬液投与部材 | |
| RU2410302C2 (ru) | Одноходовой клапанный блок | |
| MX2008005432A (en) | Dispenser for a liquid | |
| HK1129645A (en) | One way valve assembly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20121106 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |